109 related articles for article (PubMed ID: 16091478)
1. Estrogen replacement in women of fertile years with hypopituitarism.
Mah PM; Webster J; Jönsson P; Feldt-Rasmussen U; Koltowska-Häggström M; Ross RJ
J Clin Endocrinol Metab; 2005 Nov; 90(11):5964-9. PubMed ID: 16091478
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.
Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA
Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915
[TBL] [Abstract][Full Text] [Related]
4. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
[TBL] [Abstract][Full Text] [Related]
5. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
Franco C; Johannsson G; Bengtsson BA; Svensson J
J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
[TBL] [Abstract][Full Text] [Related]
7. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
[TBL] [Abstract][Full Text] [Related]
8. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.
Birzniece V; Meinhardt U; Gibney J; Johannsson G; Baxter RC; Seibel MJ; Ho KK
J Clin Endocrinol Metab; 2010 May; 95(5):2099-106. PubMed ID: 20207825
[TBL] [Abstract][Full Text] [Related]
11. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
13. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
[TBL] [Abstract][Full Text] [Related]
14. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
Kam GY; Leung KC; Baxter RC; Ho KK
J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
[TBL] [Abstract][Full Text] [Related]
15. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults.
Cook DM; Ludlam WH; Cook MB
J Clin Endocrinol Metab; 1999 Nov; 84(11):3956-60. PubMed ID: 10566634
[TBL] [Abstract][Full Text] [Related]
16. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
[TBL] [Abstract][Full Text] [Related]
17. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Bellantoni MF; Harman SM; Cho DE; Blackman MR
J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
[TBL] [Abstract][Full Text] [Related]
18. Effects of aging and estradiol supplementation on GH axis dynamics in women.
Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
[TBL] [Abstract][Full Text] [Related]
19. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
[TBL] [Abstract][Full Text] [Related]
20. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
